Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44bab6d9e8e01bedc43d150958de2ecb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-249 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
1980-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec8758deec34eff343b481412d1b521 |
publicationDate |
1983-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0091543-A1 |
titleOfInvention |
Anti-interferon antibodies and method of producing same |
abstract |
Antibodies against purified human Le form interferon proteins are described. The interferon proteins are isolated by sodium dodecylsulphate polyacrylamide gradient electrophoresis as two major species of observed molecular weights 18400 ± 200 daltons and 20100 ± 200 daltons, and four minor species. Antibodies against each major species neutralise the other. The antibodies are useful in antibody affinity chromatography purification of crude interferon. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910707-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0119476-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0119476-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557967-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7582445-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087726-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8349331-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5676942-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9015817-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5503828-A |
priorityDate |
1979-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |